ALLARITY THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4549 USD | -2.76% |
|
-9.20% | -95.87% |
| 05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
| 05-14 | Allarity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.76% | -9.20% | -95.87% | -99.70% | - | 8.01M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALLR Stock
- Charts Allarity Therapeutics, Inc.
- Comparison Chart